Artificial intelligence helps doctors spot more cases of breast cancer when reading routine scans, a world-first trial found Friday. The trial involved more than 100,000 women who received routine breast cancer scans across Sweden in 2021 and 2022. Nine percent more cancer cases were spotted in the AI group compared to the control group. Stephen Duffy, emeritus professor of cancer screening at Queen Mary University of London who was not involved in the study, said it provided further evidence that AI-assisted cancer screening is safe. More than 2.3 million women were diagnosed with breast cancer and 670,000 died from the disease in 2022, according to the World Health Organization.